Ardelyx, Inc.
(NASDAQ : ARDX)

( )
ARDX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.12%182.300.7%$1409.86m
MRKMerck & Co., Inc. -0.27%93.020.7%$1238.06m
PFEPfizer Inc. -0.04%51.680.9%$1233.71m
BMYBristol-Myers Squibb Co. -0.17%78.861.0%$1135.54m
LLYEli Lilly & Co. -0.10%325.351.1%$1134.85m
ABBVAbbVie, Inc. 0.22%152.881.9%$1021.46m
AZNAstraZeneca Plc -0.85%66.331.0%$448.24m
SGENSeagen Inc. -1.61%176.455.7%$320.77m
GSKGSK Plc -0.53%43.460.2%$295.87m
TPTXTurning Point Therapeutics, Inc. 0.00%75.170.0%$291.93m
MRTXMirati Therapeutics, Inc. 2.70%70.001.6%$204.79m
SIGASIGA Technologies, Inc. -8.82%11.890.0%$200.31m
HZNPHorizon Therapeutics Plc 0.00%85.135.4%$182.59m
NVSNovartis AG 0.07%84.880.2%$167.87m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.15%144.000.0%$147.86m

Company Profile

Ardelyx, Inc. is a biopharmaceutical company. engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.